AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Siglyn M 50/500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Siglyn M 50/500 Tablet SR

Diabetics with type 2 mellitus may be prescribed the dual-action tablet, Siglyn M 50/500 SR, to manage elevated blood glucose. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening heart attack and stroke risk. Siglyn M 50/500 SR can be used as monotherapy or in conjunction with other anti-diabetic treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and current medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Adherence to the recommended diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all individuals. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting treatment. Pregnant or lactating individuals must consult their doctor. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout treatment.

Primary Ingredients of Siglyn M 50/500 Tablet SR

The provided text is "undefined," so no rewriting is possible.

Uses of Siglyn M 50/500 Tablet SR

Managing type 2 diabetes

Major Benefits of Siglyn M 50/500 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Siglyn M 50/500 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.

Common Side effects of Siglyn M 50/500 Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siglyn M 50/500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Siglyn M 50/500 Tablet SR. Ingest the tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Siglyn M 50/500 Tablet SR works:

Siglyn M 50/500 SR tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Siglyn M 50/500 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Siglyn M 50/500 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Siglyn M 50/500 tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Siglyn M 50/500 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Siglyn M 50/500 SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.

LiverLiverUNSAFE

Patients with liver conditions should likely not take Siglyn M 50/500 SR tablets; this medication is potentially harmful in such cases and requires medical oversight. A physician's consultation is recommended.

What if you forget to take Siglyn M 50/500 Tablet SR :

Should you forget to take a Siglyn M 50/500 Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Siglyn M 50/500 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siglyn M 50/500 Tablet SR

Siglyn M 50/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Prolonged use of Siglyn M 50/500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Siglyn M 50/500 Tablet SR may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Siglyn M 50/500 Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Siglyn M 50/500 Tablet SR is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Siglyn M 50/500 Tablet SR) can rarely cause lactic acidosis, a serious medical emergency with elevated blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siglyn M 50/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglyn M 50/500 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Siglyn M 50/500 Tablet SR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglyn M 50/500 Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 50/500 Tablet SR) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This risk is increased in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M 50/500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglyn M 50/500 SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglyn M 50/500 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Siglyn M 50/500 Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siglyn M 50/500 Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 50/500 Tablet SR) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Siglyn M 50/500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Siglyn M 50/500 Tablet SR
131